You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
- 2. Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma
- 3. Nwd1 gene deletion triggers MASH-like pathology in mice
- 4. Unlocking the hidden proteome: The role of coding circular RNA in cancer
- 5. How environmental exposures affect genes and increase cancer risk
- 6. Secret boss of the liver: Star-shaped cells that promote fibrosis also regulate liver health
- 7. Prostate cancer is not a death knell, study shows
- 8. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
- 9. Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035
- 10. Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
Last updated at 21:27 GMT
Hot News Makers
Health/Pharma Companies
-
63574.83
-
45282.26
-
27445.73
-
11343.37
-
8498.78
-
8076.55
-
7830.57
-
6872.69
-
6616.71
-
5966.82
Drugs, Treatments, Trials
-
18924.71
-
7063.73
-
6336.32
-
6210.12
-
5130.42
-
4832.35
-
4240.63
-
3951.15
-
3271.92
-
2776.72
Last updated at 21:10 GMT
